ICP-248 With Azacitidine
A Phase 1 Study of ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies.
Near Add Your Location
Center of Excellence
- Accepting patients
Center of Excellence
Smilow Cancer Hospital at Yale New Haven
New Haven, CT
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.